nimbolide has been researched along with ceruletide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslam Saifi, M; Bansod, S; Godugu, C; Khurana, A | 1 |
| Bansod, S; Godugu, C | 1 |
2 other study(ies) available for nimbolide and ceruletide
| Article | Year |
|---|---|
Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way.
Topics: Animals; Anti-Inflammatory Agents; beta Catenin; Ceruletide; Cytokines; Disease Models, Animal; Extracellular Matrix; Fibrosis; Inflammation Mediators; Limonins; Male; Mice; Oxidative Stress; Pancreas; Pancreatitis, Chronic; Phosphorylation; Signal Transduction; Sirtuin 1; Smad2 Protein; Smad3 Protein | 2020 |
Nimbolide ameliorates pancreatic inflammation and apoptosis by modulating NF-κB/SIRT1 and apoptosis signaling in acute pancreatitis model.
Topics: alpha-Amylases; Animals; Apoptosis; Ceruletide; Edema; Injections, Intraperitoneal; Limonins; Male; Mice; NF-kappa B; Oxidative Stress; Pancreas; Pancreatitis; RAW 264.7 Cells; Signal Transduction; Sirtuin 1 | 2021 |